Go to ...

Boston News Globe

News Network

RSS Feed

July 22, 2018

​Biogen loses chief scientific officer, but agrees to fund his Harvard lab

A prominent Harvard Medical School professor has quietly left his post as the chief scientific officer of Biogen, but will still receive research funding from the Cambridge biotech.

Biogen (Nasdaq: BIIB) disclosed in its proxy statement last month that Spyros Artavanis-Tsakonas, who was named permanent CSO in 2013, is now serving in the more limited role of part-time “visiting scientist.” According to the filing, Biogen reached an agreement with Harvard in January under which it will pay the…

Source: Boston Biz

More Stories From Money